Business programme

Kirill Kaem, whose family have been doctors for no fewer than seven generations, graduated from the Kirov State Medical Academy in Nizhny Novgorod in 1992. Five years later he graduated with distinction from the economics department at the Lobachevsky State University, after successfully completing his studies in Russia and the USA on an MBA program run jointly with Taylor University. He has over 20 years' experience in senior management roles, including 15 years as a CEO at the corporation's various international branches. He specializes in launching start-ups in new regions and countries, and new business areas at major firms. From 1992 to 1994 he owned his own business, distributing medical equipment and pharmaceuticals. In 1995 Kirill Kaem set up a network of regional outlets for the Swedish company Oriflame in the Volga Region, which helped it become one of the region's biggest tax-payers. In the year 2000 he began working in Germany, in the central office of the company Varta. After Varta's merger with the American group Spectrum Brands, he spent eight years in overall charge of the company's operations in Russia. In 2008 he relaunched the German and American holding JAFRA International in Russia, improving profit margins by 40%. In 2009 he took control of the Russian holding Hygiene Kinetics, the biggest manufacturer in the market for domestic paper and cellulose products. Within two years the company's sales growth was several times higher than average growth in the sector, thanks to the introduction of new technologies. From 2011 to 2013 he headed up a new area of business at 'Alpha Group' - the biggest federal chain of clinics, 'Alpha Health Centre', where in the space of a year he managed to double revenue, whilst the chain itself saw profits rise by over a third. From 2013 onwards he has been a member of the Board of Directors and a co-founder of the international medical centre 'Medcluster', set up at the initiative of Sberbank in partnership with Strategy Group Partners, with Johns Hopkins Medicine International as a potential partner. From 2013-2017 he was director of the Skolkovo Foundation’s biomed cluster.

Born on March 15, 1973 in Jaipur, India. Russian citizen.
Graduated from Birla Public School in Pilani. In 1992 started his higher education in Russia, at Irkutsk State Medical University. Later graduated from the Far Eastern Federal University, majoring in Finance and Credit. Married, with three children.
Founder of Pharmasyntez, member of the Leaders’ Club to Promote Business Initiatives (a non-profit partnership), Co-Chairman of the Business Council for Cooperation with India, participant in several investment forums and business missions.
Pharmasyntez manufactures medicinal drugs for socially significant diseases, such as tuberculosis, HIV/AIDS, cancer, hepatitis and diabetes. The company’s profile includes over 113 various pharmaceutical forms and dosages – caps, pills, granules, IV solutions, sterile dry powders, solutions for injection and lyophilisates. Currently Pharmasyntez has five GMP compliant manufacturing facilities in the following Russian cities: Saint Petersburg, Tyumen, Bratsk, Irkutsk and Ussuriysk. The company employs over 1500 qualified specialists.
Pharmasyntez was number one Russian pharmaceutical manufacturer based on hospital purchases in 2016 (and No. 5 out of all pharmaceutical manufacturers, based on hospital purchases records). In 2016 it also became the fastest growing Russian manufacturing company with the revenue of 12 billion, which has doubled in comparison with 2014.
Currently Pharmasyntez is Russia’s leader in manufacturing medicinal agents for tuberculosis, retrovirus and cancer. Farmasintez does innovative R&D and exports pharmaceutical agents from Russia. The company is Irkutsk’s biggest tax payer.

Oleg Teplov is the Chief Executive Officer of VEB Innovations, a subsidiary of Vnesheconombank (VEB) Group, a Russian economist, banker, and financier. He is one of the creators of the National Technology Initiative state program.

Oleg Teplov has been working in the finance industry and public sector for about 20 years, specializing in technological development of the Russian economy. Before joining VEB Innovations, Oleg held the position of referent at the Expert Directorate with the President of the Russian Federation, where he was involved in the development and implementation of the National Technology Initiative (NTI) and drafting the Digital Economy of Russia state program. As a referent at the directorate, he created the system of NTI governance and expansion and developed the National Ranking of Investment Climate in the Constituent Territories of the Russian Federation.

Oleg also leads the Strategic Planning Unit of the Economy and Finance Department at the Executive Office of the Government of Russia, as well as the Strategic Planning Department at the Ministry of Economic Development, where he coordinated the activities of the Strategic Initiatives Agency, Industrial Development Fund, Roseximbank, MSP Bank, and Russian Direct Investment Fund. He also held executive positions in major Russian banks and the global “Big Four” auditing firms.

At present, VEB Innovations under Oleg Teplov's management makes high-risk direct investments in technology-related projects, creates venture funds jointly with major Russian corporations and global partners, as well as fostering investment and technology cooperation with R&D centers, major businesses, and development institutions.

Special attention in his activities is paid to high-potential ICT (information and communication technology) and other projects for the space industry, vertical marketplace initiatives, as well as investments in artificial intelligence, robotics, online education services, and telemedicine. Pharmaceuticals, biotechnology, and new energy-related technologies are prioritized as well.

Before joining Petrovax in 2018, Mikhail Tsyferov gained extensive experience in a number of large investment companies.
From 2018 to present – President of NPO Petrovax Pharm LLC (part of the Interros Group), Member of the Board of Directors.
From 2016 to present – Managing Director of the Winter Capital Fund.
From 2008 to 2016 – manager of the investment department of Interros.
From 2007 to 2008 – employee of the capital markets department at Renaissance Capital.
Acted as an investor in more than 20 Private equity / VC transactions.
He graduated from the School of International Economic Relations of MGIMO (Moscow State Institute of International Relations) in 2007.

Maria Grudina graduated with honors from the St. Petersburg University of Economics and Finance in 2008 with a major in World Economics. In 2014, she completed the program “Management in the international hospitality industry” at the Russian-Swiss business school SWISSAM.

In 2018-2019, she completed the Leadership Development Program at the Skolkovo Business School.

Maria has been working in the field of real estate and hospitality for more than 10 years, and for 3 years in healthcare.

Since 2009, she worked as Executive
Director of the non-profit organization called “Real Estate Market Consumer Center” and was the CEO of the “Life” hotel.

In 2016, Maria began her work with the “Pioneer” group of companies, and founded the project “First Line. Health Care Resort ”. Maria is developing this project to the present. The launch of the resort took place in January 2018. The official opening with the participation of the Governor of St. Petersburg was held on the Day 0 of the Economic Forum on May 23, 2018. The project became the leader of preventive rehabilitation in St. Petersburg and Russia in a short time. As part of the work of the First Line, in November 2018 the first international conference on prevent age in St. Petersburg was held with the support of the SPB Government. More than 3,800 people have attended health improvement programs at the resort.

In 2019, she received the award “Influential Women of St. Petersburg” from Business Petersburg, and won the Sobaka.ru magazine award “TOP 50.Most famous people of St. Petersburg”.

Maria is married with three children, speaks English and French, enjoys Pilates and healthy lifestyle. She has written a short stories book, and studies the methodology of thinking.

Ruslan Khalfin is Director of the Higher School of Healthcare Management at the I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, a medical doctor, Professor, winner of a State Prize of the Russian Federation in the field of science and technology, Honoured Doctor of the Russian Federation, and Actual State Councillor of Russian Federation, 2nd class. He worked for more than 30 years in healthcare in the Sverdlovsk Region. He has also worked in the central office of the Ministry of Health of the Russian Federation and the Ministry of Health and Social Development of the Russian Federation, and has held the post of Deputy Minister under three federal ministers. He has been actively involved in reforming the sector, and was one of the originators and implementers of the national ‘Health’ project. For the past 11 years he has been President of the medical insurance company MAKS-M, part of the MAKS Insurance Group. Chair of the Board of the Russia-wide public organization ‘The Russian Association for the Organization of Health and Public Health’.

Director of the Medical Research and Educational Centre of the Lomonosov Moscow State University, Head of the Urology and Andrology School of the Department of Fundamental Medicine of the Lomonosov Moscow State University, Academician of the Russian Academy of Sciences, Professor, Doctor of Medicine, Honoured Scientist of the Russian Federation.
The central focus of scientific research and practice:
Armais Kamalov’s scientific research focuses on urology, andrology and fundamental medicine. He is the author of many research papers, including monographs, textbooks, books, manuals, and patents for inventions. He is the author of many research papers, including monographs, textbooks, books, manuals, and patents for inventions. He was a scientific advisor of 5 doctoral and ten master’s theses. In 1992, he passed Candidate’s thesis defence, in 1998 – PhD thesis defence. Both focused on scientific rationale and introduction of radically new endoscopic methods of treatment of urological diseases.
Many years of scientific research and medical practice Armais Kamalov devoted to the development and implementation of high-tech minimally invasive methods of diagnosis and treatment of urological diseases, which significantly improved the outcome of treatment of many urological disorders.
In recent years, he has been devoting much attention to establishing a new medicine based on an interdisciplinary approach to solving men's health problems and improving reproductive health. Through his direct involvement, the organization of a programme to protect the health of the male population, including the setting up specialized medical clinics was successfully implemented in the regions of the Russian Federation.
Honours, awards
• Medal for Labour Valour (1997)
• Order of Honour 3rd Class (2006)
• Winner of the Prizvanie (Vocation) National Award ‘The Best Doctor of Russia’ nomination ‘For Breaking a New Medical Ground’ (2006)
• Lopatkin Award Winner ‘For the Contribution to the Development of Russian Urology’ (2007 & 2012)
• Medal ‘For Contribution to International Cooperation’ (2011)
• State Award ‘For Active Citizenship and Valuable Contribution to the Public and Political Life’
• Excellent Worker of Public Health (2012)
• Honoured Scientist of the Russian Federation (2016)
• Certificate of Appreciation ‘For Merit to the Urban Community’ (2019)
Armais Kamalov is a prominent scientist, teacher, top ranking urologist, who have mastered the most advanced treatment of urological diseases, a thought leader home and abroad. He is a well-regarded professional in public and professional communities.